Winton Capital »

Denali Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $210k 13k 16.51
2021-12-31 $280k 6.3k 44.64
2019-12-31 $792k 46k 17.42